Literature DB >> 24777192

Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion.

M Yabe1, T Morimoto2, T Shimizu2, T Koike2, H Takakura2, K Ohtsubo2, A Fukumura2, S Kato1, H Yabe1.   

Abstract

We retrospectively studied 108 marrow harvests from 105 pediatric sibling donors. The median age of donors was 8 years (range: 1-15) and the median body weight was 27 kg (range: 10-100). The volumes of aspirated marrow were 5.0-23.8 mL/kg donor body weight, and harvested bone marrow volume exceeded 15 mL/kg in 42% of the donors. A total of 100 autologous blood donations were performed, and eight donors had red cells salvaged from their harvests reinfused. The median Hb levels before and after harvests were 12.3 g/dL (range: 10.0-14.7) and 11.0 g/dL (range: 8.9-13.8), respectively. None of the donors received allogeneic blood transfusions or hematopoietic growth factors such as EPO and G-CSF before or after collection. Transplanted dose was 1.4-10.8 × 10(8) cells/kg recipient body weight without differences due to donor age. Higher concentrations of nucleated and CD34(+) cells were obtained from younger donors. All donors tolerated the procedures well, with no serious complications. Thus, children may safely donate marrow for allogeneic transplantation, and the yields of nucleated cells for engraftment are substantial.

Entities:  

Mesh:

Year:  2014        PMID: 24777192     DOI: 10.1038/bmt.2014.73

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  20 in total

1.  Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study.

Authors:  Jan Styczynski; Adriana Balduzzi; Lidia Gil; Myriam Labopin; Rose-Marie Hamladji; Sarah Marktel; M Akif Yesilipek; Franca Fagioli; Karoline Ehlert; Martina Matulova; Jean-Hugues Dalle; Jacek Wachowiak; Maurizio Miano; Chiara Messina; Miguel Angel Diaz; Christiane Vermylen; Matthias Eyrich; Isabel Badell; Peter Dreger; Jolanta Gozdzik; Daphna Hutt; Jelena Rascon; Giorgio Dini; Christina Peters
Journal:  Blood       Date:  2011-12-12       Impact factor: 22.113

2.  Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.

Authors:  Hyery Kim; Hyoung Jin Kang; Ji Won Lee; Kyung Duk Park; Hee Young Shin; Hyo Seop Ahn
Journal:  Ann Hematol       Date:  2011-11-12       Impact factor: 3.673

3.  Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Authors:  J P Halter; S M van Walraven; N Worel; M Bengtsson; H Hägglund; G Nicoloso de Faveri; B E Shaw; A H Schmidt; M Fechter; A Madrigal; J Szer; M D Aljurf; D Weisdorf; M M Horowitz; H Greinix; D Niederwieser; A Gratwohl; Y Kodera; D Confer
Journal:  Bone Marrow Transplant       Date:  2012-07-09       Impact factor: 5.483

Review 4.  Pre-operative predeposit autologous donation in children presenting for elective surgery: a review.

Authors:  G R Lauder
Journal:  Transfus Med       Date:  2007-04       Impact factor: 2.019

5.  Preoperative autologous blood donation for cardiac surgery in children.

Authors:  Narutoshi Hibino; Mitsugi Nagashima; Harumitsu Sato; Takaki Hori; Hitoshi Ishitoya; Tetsuo Tomino
Journal:  Asian Cardiovasc Thorac Ann       Date:  2008-01

6.  Age-related changes in human hematopoietic stem/progenitor cells.

Authors:  Klaudia Kuranda; Jacques Vargaftig; Philippe de la Rochere; Christine Dosquet; Dominique Charron; Florence Bardin; Cecile Tonnelle; Dominique Bonnet; Michele Goodhardt
Journal:  Aging Cell       Date:  2011-03-22       Impact factor: 9.304

7.  Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.

Authors:  M A Pulsipher; J E Levine; R J Hayashi; K W Chan; P Anderson; R Duerst; I Osunkwo; V Fisher; B Horn; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

8.  Marrow harvesting from normal donors.

Authors:  C D Buckner; R A Clift; J E Sanders; P Stewart; W I Bensinger; K C Doney; K M Sullivan; R P Witherspoon; H J Deeg; F R Appelbaum
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

9.  A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.

Authors:  Haydar Frangoul; Eneida R Nemecek; Dean Billheimer; Michael A Pulsipher; Shakila Khan; Ann Woolfrey; Becky Manes; Catherine Cole; Mark C Walters; Mouhab Ayas; Yaddanapudi Ravindranath; John E Levine; Stephan A Grupp
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

10.  Pediatric bone marrow cellularity: are we expecting too much?

Authors:  S E Friebert; L B Shepardson; S B Shurin; G E Rosenthal; N S Rosenthal
Journal:  J Pediatr Hematol Oncol       Date:  1998 Sep-Oct       Impact factor: 1.289

View more
  2 in total

1.  Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy.

Authors:  Francesca Tucci; Marta Frittoli; Federica Barzaghi; Valeria Calbi; Maddalena Migliavacca; Francesca Ferrua; Francesca Fumagalli; Laura Lorioli; Laura Castagnaro; Marcella Facchini; Claudia Fossati; Stefano Zancan; Paola Massariello; Michele Manfredini; Giulia Consiglieri; Daniele Canarutto; Salvatore Recupero; Francesco Calzatini; Miriam Casiraghi; Silvia Darin; Gigliola Antonioli; Roberto Miniero; Rossana Fiori; Paolo Silvani; Matilde Zambelli; Sarah Marktel; Salvatore Gattillo; Raffaella Milani; Luca Santoleri; Fabio Ciceri; Alessandra Biffi; Maria Pia Cicalese; Maria Ester Bernardo; Alessandro Aiuti
Journal:  Bone Marrow Transplant       Date:  2019-05-31       Impact factor: 5.483

2.  Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.

Authors:  Matthias Kollek; Gesina Voigt; Christian Molnar; Fabronia Murad; Daniela Bertele; Christopher Felix Krombholz; Sheila Bohler; Verena Labi; Stefan Schiller; Mirjam Kunze; Stephan Geley; Charlotte M Niemeyer; Ana Garcia-Saez; Miriam Erlacher
Journal:  J Exp Med       Date:  2017-09-07       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.